Gross profit was down 1.8% to $47.6 million (a GP margin of 43.0%).
After-tax profit rose 40% to $13.2 million, reflecting significantly lower interest expense and $1.9 million one-off insurance proceeds.
There was no goodwill impairment for the year and profit before tax of $18,910 was described as ‘not meaningful’ as was profit after tax of $13,211.
Bank debt was reduced from $47.5 million to $38.5 million during the year, leaving net debt of $27.0 million as at 30 June.
A fully-franked final dividend of 1.25c per ordinary share was recommended by directors. The shares have been trading at about 71.5c.
Landmark eye and face transplant recipient recording retinal response to light, says report
Almost 18 months after a world-first whole eye and facial transplant, there is no sign of rejection and some indication...
